Sandy Smith

Track

Insider profile

Currently holds positions in Genzyme Corp, Palisade Bio Inc and Akcea Therapeutics Inc

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return -0% 8.2% 15.1%
Success rate 76% 68% 82%
Transactions
13 15% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Executive Vice President, President - International Group Genzyme Corp June 1, 2006 -
Independent Director Palisade Bio Inc March 1, 2014 -
Independent Director Akcea Therapeutics Inc March 15, 2017 -
Independent Director Seelos Therapeutics Inc Aug. 5, 2014 - Jan. 24, 2019
Sandy Smith's trades of Cytokinetics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
305.25
Quantity 20,449 -11.1%
Value US$2,051,847
Transaction date
Sale
Price
408.20
Quantity 73,422 -1.7%
Value US$4,678,827
Transaction date
Sale
Price
63.10
Quantity 1,171 +21.5%
Value US$1,146,596
Transaction date
Sale
Price
41.21
Quantity 5,000 -42.5%
Value US$206,027
Transaction date
Planned sale
Price
28.50
Quantity 5,000 -43.6%
Value US$142,500
Transaction date
Planned sale
Price
29.50
Quantity 1,965 -23.3%
Value US$57,968
Transaction date
Planned sale
Price
29.00
Quantity 5,000 -43.6%
Value US$145,000
Transaction date
Planned sale
Price
28.00
Quantity 5,000 -84.5%
Value US$140,000
Transaction date
Planned sale
Price
27.50
Quantity 4,739 -83.7%
Value US$130,322
Transaction date
Planned sale
Price
26.50
Quantity 5,000 -84.5%
Value US$132,500
Transaction date
Planned sale
Price
25.00
Quantity 5,714 -86.1%
Value US$142,850
Transaction date
Planned sale
Price
25.50
Quantity 5,000 -84.5%
Value US$127,500
Transaction date
Planned sale
Price
30.00
Quantity 5,936 -100.0%
Value US$178,080
Transaction date
Planned sale
Price
29.00
Quantity 6,667 -100.0%
Value US$193,343
Transaction date
Planned sale
Price
28.00
Quantity 6,667 -100.0%
Value US$186,676
Transaction date
Planned sale
Price
27.00
Quantity 1,434 -100.0%
Value US$38,718
Transaction date
Planned sale
Price
26.00
Quantity 6,510 -100.0%
Value US$169,260
Transaction date
Planned sale
Price
27.00
Quantity 5,232 -100.0%
Value US$141,264
Transaction date
Sale
Price
24.00
Quantity 5,000 -100.0%
Value US$120,000
Transaction date
Sale
Price
25.00
Quantity 5,000 -100.0%
Value US$125,000
Transaction date
Sale
Price
23.00
Quantity 2,741 -100.0%
Value US$63,043
Transaction date
Sale
Price
23.00
Quantity 4,166 -100.0%
Value US$95,818
Transaction date
Sale
Price
22.00
Quantity 6,666 -100.0%
Value US$146,652
Transaction date
Sale
Price
21.10
Quantity 4,166 -100.0%
Value US$87,903
Transaction date
Sale
Price
20.77
Quantity 10,879 -100.0%
Value US$226,005
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-09-02 2022-09-02
S Sale
20,449 -11.1%
305.25
US$2,051,847 		20,449 -11.1% 305.25 US$2,051,847
2021-11-19 2021-11-19
S Sale
73,422 -1.7%
408.20
US$4,678,827 		73,422 -1.7% 408.20 US$4,678,827
2021-11-19 2021-11-19
S Sale
1,171 +21.5%
63.10
US$1,146,596 		1,171 +21.5% 63.10 US$1,146,596
2021-11-19 2021-11-19
S Sale
5,000 -42.5%
41.21
US$206,027 		5,000 -42.5% 41.21 US$206,027
2021-07-21 2021-07-19
PlS Planned sale
5,000 -43.6%
28.50
US$142,500 		5,000 -43.6% 28.50 US$142,500
2021-07-21 2021-07-19
PlS Planned sale
1,965 -23.3%
29.50
US$57,968 		1,965 -23.3% 29.50 US$57,968
2021-07-21 2021-07-19
PlS Planned sale
5,000 -43.6%
29.00
US$145,000 		5,000 -43.6% 29.00 US$145,000
2021-04-27 2021-04-27
PlS Planned sale
5,000 -84.5%
28.00
US$140,000 		5,000 -84.5% 28.00 US$140,000
2021-04-27 2021-04-27
PlS Planned sale
4,739 -83.7%
27.50
US$130,322 		4,739 -83.7% 27.50 US$130,322
2021-04-23 2021-04-23
PlS Planned sale
5,000 -84.5%
26.50
US$132,500 		5,000 -84.5% 26.50 US$132,500
2021-04-15 2021-04-15
PlS Planned sale
5,714 -86.1%
25.00
US$142,850 		5,714 -86.1% 25.00 US$142,850
2021-04-15 2021-04-15
PlS Planned sale
5,000 -84.5%
25.50
US$127,500 		5,000 -84.5% 25.50 US$127,500
2020-10-05 2020-10-05
PlS Planned sale
5,936 -100.0%
30.00
US$178,080 		5,936 -100.0% 30.00 US$178,080
2020-07-17 2020-07-15
PlS Planned sale
6,667 -100.0%
29.00
US$193,343 		6,667 -100.0% 29.00 US$193,343
2020-07-13 2020-07-10
PlS Planned sale
6,667 -100.0%
28.00
US$186,676 		6,667 -100.0% 28.00 US$186,676
2020-07-09 2020-07-08
PlS Planned sale
1,434 -100.0%
27.00
US$38,718 		1,434 -100.0% 27.00 US$38,718
2020-07-09 2020-07-07
PlS Planned sale
6,510 -100.0%
26.00
US$169,260 		6,510 -100.0% 26.00 US$169,260
2020-07-09 2020-07-07
PlS Planned sale
5,232 -100.0%
27.00
US$141,264 		5,232 -100.0% 27.00 US$141,264
2020-06-22 2020-06-22
S Sale
5,000 -100.0%
24.00
US$120,000 		5,000 -100.0% 24.00 US$120,000
2020-06-22 2020-06-22
S Sale
5,000 -100.0%
25.00
US$125,000 		5,000 -100.0% 25.00 US$125,000
2020-06-17 2020-06-17
S Sale
2,741 -100.0%
23.00
US$63,043 		2,741 -100.0% 23.00 US$63,043
2020-06-17 2020-06-17
S Sale
4,166 -100.0%
23.00
US$95,818 		4,166 -100.0% 23.00 US$95,818
2020-06-15 2020-06-15
S Sale
6,666 -100.0%
22.00
US$146,652 		6,666 -100.0% 22.00 US$146,652
2020-06-12 2020-06-12
S Sale
4,166 -100.0%
21.10
US$87,903 		4,166 -100.0% 21.10 US$87,903
2020-06-12 2020-06-12
S Sale
10,879 -100.0%
20.77
US$226,005 		10,879 -100.0% 20.77 US$226,005
2014-10-24 2014-10-23
B Purchase
18,200 +219.3%
1.59
US$28,998 		18,200 +219.3% 1.59 US$28,998
2014-10-24 2014-10-22
B Purchase
8,300 +inf%
1.52
US$12,651 		8,300 +inf% 1.52 US$12,651